This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Imbruvica
  • /
  • Autologous Transplantation After a Rituximab/Ibrut...
Clinical trial

Autologous Transplantation After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma - a Randomized European Mcl Network Trial

Read time: 2 mins
Last updated:30th Jun 2016
Identifier: NCT02858258
The primary objective of the the trial is to establish one of three study arms, as future standard based on the comparison of the investigator-assessed failure-free survival.
Category Value
Date last updated at source 2016-03-06
Study type(s) Interventional
Expected enrolment 870
Study start date 2016-07-01
Estimated primary completion date 2021-05-01

View full details